PTC Therapeutics Inc. buy Wells Fargo & Company
Start price
29.07.25
/
50%
€43.60
Target price
29.07.26
€67.26
Performance (%)
-11.01%
Price
07:36
?
Summary
This prediction is currently active. The price of PTC Therapeutics Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -11.01%. This prediction currently runs until 29.07.26. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| PTC Therapeutics Inc. | -12.442% |
| iShares Core DAX® | 1.043% |
| iShares Nasdaq 100 | 1.920% |
| iShares Nikkei 225® | 4.840% |
| iShares S&P 500 | 1.567% |
Comments by Wells_Fargo___Compan for this prediction
In the thread PTC Therapeutics Inc. diskutieren
PTC Therapeutics, Inc. (NASDAQ: PTCT) had its price target raised by analysts at Wells Fargo & Company from $74.00 to $78.00. They now have an "overweight" rating on the stock.
Ratings data for PTCT provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for PTC Therapeutics Inc.
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€39.00
08.08.25
08.08.25
€67.74
08.08.26
08.08.26
-0.51%
07:36
07:36
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€41.80
27.05.25
27.05.25
€64.95
27.05.26
27.05.26
-8.61%
07:36
07:36
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€45.40
26.11.24
26.11.24
€64.72
26.11.25
26.11.25
-14.54%
07:36
07:36
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€24.20
08.12.23
08.12.23
€34.41
08.12.24
08.12.24
78.51%
09.12.24
09.12.24